Ra Capital Management as of Dec. 31, 2025
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 71 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A/s - SH (ASND) | 22.5 | $2.2B | 10M | 213.24 | |
| Cidara Therapeutics SH (CDTX) | 7.6 | $743M | 3.4M | 220.89 | |
| Rhythm Pharmaceuticals SH (RYTM) | 7.3 | $714M | 6.7M | 107.04 | |
| Avidity Biosciences SH | 6.4 | $623M | 8.6M | 72.13 | |
| Vaxcyte SH (PCVX) | 5.1 | $495M | 11M | 46.14 | |
| Sionna Therapeutics SH (SION) | 4.2 | $408M | 9.9M | 41.14 | |
| Newamsterdam Pharma Co Nv SH (NAMS) | 3.4 | $335M | 9.6M | 35.08 | |
| Tyra Biosciences SH (TYRA) | 3.3 | $321M | 12M | 26.29 | |
| Wave Life Sciences SH (WVE) | 3.2 | $310M | 18M | 17.00 | |
| Mineralys Therapeutics SH (MLYS) | 2.7 | $266M | 7.3M | 36.29 | |
| Edgewise Therapeutics SH (EWTX) | 2.7 | $259M | 10M | 24.82 | |
| Septerna SH (SEPN) | 2.0 | $195M | 7.0M | 27.88 | |
| Nuvalent Inc-a SH (NUVL) | 1.9 | $189M | 1.9M | 100.59 | |
| Disc Medicine SH (IRON) | 1.6 | $157M | 2.0M | 79.41 | |
| Janux Therapeutics SH (JANX) | 1.6 | $154M | 11M | 13.80 | |
| Pepgen SH (PEPG) | 1.3 | $131M | 20M | 6.51 | |
| Taysha Gene Therapies SH (TSHA) | 1.3 | $130M | 24M | 5.50 | |
| Ars Pharmaceuticals SH (SPRY) | 1.3 | $127M | 11M | 11.65 | |
| Biocryst Pharmaceuticals SH (BCRX) | 1.3 | $124M | 16M | 7.80 | |
| Bicara Therapeutics SH (BCAX) | 1.2 | $117M | 7.0M | 16.83 | |
| Praxis Precision Medicines I SH (PRAX) | 1.1 | $110M | 374k | 294.74 | |
| Gh Research SH (GHRS) | 1.0 | $98M | 7.7M | 12.70 | |
| Geron Corp SH (GERN) | 0.9 | $84M | 64M | 1.32 | |
| Arcellx SH (ACLX) | 0.8 | $83M | 1.3M | 65.20 | |
| Vor Biopharma SH (VOR) | 0.7 | $71M | 5.4M | 13.08 | |
| Belite Bio Inc - SH (BLTE) | 0.7 | $69M | 433k | 159.96 | |
| Fulcrum Therapeutics SH (FULC) | 0.7 | $69M | 6.1M | 11.31 | |
| Lenz Therapeutics SH (LENZ) | 0.7 | $67M | 4.2M | 16.00 | |
| Dianthus Therapeutics SH (DNTH) | 0.7 | $66M | 1.6M | 41.21 | |
| Olema Pharmaceuticals SH (OLMA) | 0.7 | $65M | 2.6M | 25.00 | |
| Evommune SH (EVMN) | 0.6 | $59M | 3.5M | 17.12 | |
| Jade Biosciences SH (JBIO) | 0.6 | $57M | 3.7M | 15.43 | |
| Spyre Therapeutics SH (SYRE) | 0.5 | $53M | 1.6M | 32.76 | |
| Lexeo Therapeutics SH (LXEO) | 0.5 | $50M | 5.0M | 9.93 | |
| Lb Pharmaceuticals SH (LBRX) | 0.5 | $49M | 2.2M | 22.26 | |
| Climb Bio SH (CLYM) | 0.5 | $45M | 11M | 4.00 | |
| Monopar Therapeutics SH (MNPR) | 0.4 | $44M | 667k | 65.30 | |
| Capricor Therapeutics SH (CAPR) | 0.4 | $44M | 1.5M | 28.86 | |
| 4d Molecular Therapeutics In SH (FDMT) | 0.4 | $42M | 5.7M | 7.50 | |
| Invivyd SH (IVVD) | 0.4 | $42M | 17M | 2.47 | |
| Artiva Biotherapeutics SH (ARTV) | 0.4 | $42M | 9.9M | 4.29 | |
| Grail SH (GRAL) | 0.4 | $37M | 428k | 85.59 | |
| Assembly Biosciences SH (ASMB) | 0.4 | $35M | 1.0M | 34.01 | |
| Solid Biosciences SH (SLDB) | 0.3 | $33M | 5.8M | 5.64 | |
| Acumen Pharmaceuticals SH (ABOS) | 0.3 | $32M | 15M | 2.11 | |
| Benitec Biopharma SH (BNTC) | 0.3 | $25M | 1.9M | 13.47 | |
| Contineum Therapeutics Inc-a SH (CTNM) | 0.3 | $25M | 2.2M | 11.43 | |
| Rezolute SH (RZLT) | 0.2 | $22M | 9.2M | 2.36 | |
| Acrivon Therapeutics SH (ACRV) | 0.2 | $20M | 8.3M | 2.41 | |
| Nkarta SH (NKTX) | 0.2 | $20M | 11M | 1.85 | |
| Ovid Therapeutics SH (OVID) | 0.2 | $18M | 11M | 1.63 | |
| Palisade Bio SH (PALI) | 0.2 | $17M | 7.1M | 2.35 | |
| Sab Biotherapeutics SH (SABS) | 0.2 | $17M | 4.4M | 3.74 | |
| C4 Therapeutics SH (CCCC) | 0.2 | $15M | 8.0M | 1.91 | |
| Medline Inc-cl A SH (MDLN) | 0.1 | $14M | 335k | 42.00 | |
| Design Therapeutics SH (DSGN) | 0.1 | $14M | 1.5M | 9.38 | |
| Inspire Medical Systems SH (INSP) | 0.1 | $13M | 142k | 92.23 | |
| Avalo Therapeutics SH (AVTX) | 0.1 | $12M | 663k | 18.16 | |
| Rani Therapeutics Holdings-a SH (RANI) | 0.1 | $12M | 8.5M | 1.35 | |
| Perceptive Capital Solutions SH (PCSC) | 0.1 | $9.8M | 750k | 13.03 | |
| Adicet Bio SH (ACET) | 0.1 | $8.0M | 948k | 8.42 | |
| Newamsterdam Pharma Co Nv-27 SH (NAMSW) | 0.1 | $7.7M | 333k | 23.00 | |
| Genedx Holdings Corp SH (WGS) | 0.1 | $7.5M | 58k | 130.06 | |
| Waystar Holding Corp SH (WAY) | 0.0 | $4.7M | 144k | 32.75 | |
| Werewolf Therapeutics SH (HOWL) | 0.0 | $4.2M | 6.7M | 0.63 | |
| Hinge Health Inc-a SH (HNGE) | 0.0 | $3.7M | 80k | 46.45 | |
| Progyny SH (PGNY) | 0.0 | $2.5M | 97k | 25.68 | |
| Qiagen SH | 0.0 | $2.1M | 44k | 47.34 | |
| Orthopediatrics Corp SH (KIDS) | 0.0 | $2.0M | 110k | 17.76 | |
| Health Catalyst SH (HCAT) | 0.0 | $1.9M | 794k | 2.39 | |
| Palatin Technologies SH (PTN) | 0.0 | $1.1M | 70k | 15.38 |